Tag: Vedanta Biosciences

Bacteria

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food...

First clinical study of a bacterial consortium for treating food allergy will initially be studied in patients with history of peanut allergy.
Vedanta Immunomodulator

Company Developing Microbiome-Derived Food Allergy Therapy Raises $27 Million

Product candidate being developed may safely induce permanent tolerance to food allergens.

Connect with Us

39,099FansLike
742FollowersFollow
2,705FollowersFollow
5,519FollowersFollow
40SubscribersSubscribe